Sie suchten nach: diméthylspiro (Französisch - Englisch)

Menschliche Beiträge

Von professionellen Übersetzern, Unternehmen, Websites und kostenlos verfügbaren Übersetzungsdatenbanken.

Übersetzung hinzufügen

Französisch

Englisch

Info

Französisch

3’,6’-bis(éthylamino)-2’,7’-diméthylspiro[isobenzofuranne-1(3h),9’-[9h]-xanthène]-3-one

Englisch

3’,6’-bis(ethylamino)-2’,7’-dimethylspiro[isobenzofuran-1(3h),9’-[9h]-xanthen]-3-one

Letzte Aktualisierung: 2014-11-21
Nutzungshäufigkeit: 5
Qualität:

Französisch

ex29322985 | 70 | 3',6'-bis(éthylamino)-2',7'-diméthylspiro[isobenzofuranne-1(3h),9'-[9h]-xanthène]-3-one | 0 % | 1.1.2007 - 31.12.2008 |

Englisch

ex29322985 | 70 | 3',6'-bis(ethylamino)-2',7'-dimethylspiro[isobenzofuran-1(3h),9'-[9h]-xanthen]-3-one | 0 % | 1.1.2007 - 31.12.2008 |

Letzte Aktualisierung: 2010-09-01
Nutzungshäufigkeit: 1
Qualität:

Französisch

ex29322985 | 70 | 3',6'-bis(éthylamino)-2',7'-diméthylspiro[isobenzofuranne-1(3h),9'-= [9h]-xanthène]-3-one | 0 | 1.1.2006- 31.12.2008 |

Englisch

ex29322985 | 70 | 3',6'-bis(ethylamino)-2',7'-dimethylspiro[isobenzofuran-1(3h),9'-= [9h]-xanthen]-3-one | 0 | 1.1.2006 to 31.12.2008 |

Letzte Aktualisierung: 2010-09-23
Nutzungshäufigkeit: 1
Qualität:

Französisch

selon l'invention, l'ajout à une composition parfumée d'un ou de plusieurs des produits suivants, de préférence au moins dans les doses minimales en masse suivantes: 1) au moins 0,25 % de 5-méthyl-2-(2-méthylpropyl-1,3-dioxane (camonal); 2) au moins 0,5 % de méthyl 1,4-diméthylcyclohexylcarboxylate (cyprisate); 3) au moins 15 % de 3-(((1-éthyloxy)éthyl)oxy)-3,7-diméthyl-1,6-octadiène (elintaal); et 4) au moins 2,5 % de 7,9-diméthylspiro(5,5)undecan-3-one (dispirone); améliore les propriétés désodorisantes de la composition de manière inattendue.

Englisch

by including in a fragrance composition one or more of the following materials, preferably at least at the following minimum amounts by weight: 1) 5-methyl-2-(2-methylpropyl-1,3-dioxane (camonal) in an amount of at least 0.25 %; 2) methyl 1,4-dimethylcyclohexylcarboxylate (cyprisate) in an amount of at least 0.5 %; 3) 3-(((1-ethyloxy)ethyl)oxy)-3,7-dimethyl-1,6-octadiene (elintaal) in an amount of at least 15 %; and 4) 7,9-dimethylspiro(5,5)undecan-3-one (dispirone) in an amount of at least 2.5 %, the properties of the composition in reducing (counteracting) malodour are enhanced to an unexpected extent.

Letzte Aktualisierung: 2011-07-27
Nutzungshäufigkeit: 1
Qualität:

Französisch

compositions de parfum comprenant entre 10 % et 30 % au total en poids d'ingrédients de parfum sélectionnés dans deux groupes, le groupe a constitué de l'acétate de (3z)-hex-3-ényle ; du 3-(1,3-benzodioxol-5-yl)-2-méthylpropanal ; du (3z)-hex-3-én-1-ol ; de la 1-[4-(méthyloxy)phényl]éthanone ; du 3-méthyl-5-phénylpentan-1-ol ; de la 5-heptyldihydrofuran-2(3h)-one ; de l'acétate de phénylméthyle ; du 2-(4-méthylcyclohex-3-én-1-yl)propan-2-ol ; de la (3e)-4-(2,6,6-triméthylcyclohex-2-én-1-yl)but-3-én-2-one ; de la (3e)-4-(2,6,6-triméthylcyclohex-1-én-1-yl)but-3-én-2-one ; du 4-hydroxy-3-(méthyloxy)benzaldéhyde ; du 1-méthyl-3-(2-méthylpropyl)cyclohexanol ; de la 7,9-diméthylspiro[5.5]undécan-3-one ; du lavandin abδsδl1111 ; du 2,4-dihydroxy-3,6-diméthylbenzoate de méthyle ; du 3,7-diméthyloctan-1-ol ; du 2-(méthyloxy)-4-propylphénol ; du rosenta ab8428tm ; du 1-{[(1r,2s)-2-(1,1-diméthyléthyl)cyclohexyl]oxy}butan-2-ol ; du headspace freesia ab7254atm ; de la 5-hexyldihydrofuran-2(3h)-one ; du [(2-méthylbutyl)oxy]acétate de prop-2-ényle ; du 1,3-benzodioxole-5-carbaldéhyde ; du [4-(1-méthyléthyl)cyclohexyl]méthanol ; de la 2-hexylcyclopent-2-én-1-one ; du (2e)-3-phénylprop-2-énoate de méthyle ; du 2,6-diméthyloct-7-én-2-ol ; du 2-méthyl-3-[4-(1-méthyléthyl)phényl]propanal ; et le groupe b constitué du 2-phényléthanol ; du 3,7-diméthyloctan-3-ol(tétrahydrolinalol), de l'acétate de 2-(méthyloxy)-4-[(1e)-prop-1-ényl]phényle ; du 4-(méthyloxy)benzaldéhyde ; de la (2e)-1-(2,6,6-triméthylcyclohex-2-én-1-yl)but-2-én-1-one ; de la bergamote ab83921111 ; de la (3e)-3-méthyl-4-(2,6,6-triméthylcyclohex-2-én-1-yl)but-3-én-2-one ; de la cyclopentadécanone ; du cyclohexadécanolide ; du 3-cyclohexylpropanoate de prop-2-ényle ; du 3-[3-(1-méthyléthyl)phényl]butanal ; du carbonate de (3z)-hex-3-ényle et de méthyle ; du (1-méthyl-2-{[(1s,3r,5r)-1,2,2-triméthylbicyclo[3.1.0]hex-3-yl]méthyl}cyclopropyl)méthanol ; du [3,3-bis(méthyloxy)propyl]benzène ; du coumarex i modta ; du propanoate de tricyclo[5.2.1.0{2l6}]déc-4-én-8-yle ; à condition que plus de 5 % mais moins de 15 % de la composition de parfum soit constituée d'ingrédients du groupe a et pour les compositions comprenant moins de 10 % d'ingrédients du groupe a que le pourcentage total des ingrédients du groupe b présents soit supérieur ou égal à la valeur de l'expression 2*(10-a%) où a% est le pourcentage total des ingrédients du groupe a dans la composition.

Englisch

perfume compositions comprise between 10% and 30% in total by weight of perfume ingredients selected from two groups, group a, group b, with the provisos that over 5% but less than 15% of the perfume composition must comprise group a ingredients, and for compositions comprising less than 10% of group a ingredients the agregate percentage of group b ingredients present must be at least equal to the expression 2*/10-a%) where a% is the total percentage of group a ingredients in the composition.

Letzte Aktualisierung: 2011-07-27
Nutzungshäufigkeit: 1
Qualität:

Französisch

compositions de parfum comprenant entre 10 % et 30 % au total en poids d'ingrédients de parfum sélectionnés dans deux groupes, le groupe a constitué de l'acétate de (3z)-hex-3-ényle ; du 3-(1,3-benzodioxol-5-yl)-2-méthylpropanal ; du (3z)-hex-3-én-1-ol ; de la 1-[4-(méthyloxy)phényl]éthanone ; du 3-méthyl-5-phénylpentan-1-ol ; de la 5-heptyldihydrofuran-2(3h)-one ; de l'acétate de phénylméthyle ; du 2-(4-méthylcyclohex-3-én-1-yl)propan-2-ol ; de la (3e)-4-(2,6,6-triméthylcyclohex-2-én-1-yl)but-3-én-2-one ; de la (3e)-4-(2,6,6-triméthylcyclohex-1-én-1-yl)but-3-én-2-one ; du 4-hydroxy-3-(méthyloxy)benzaldéhyde ; du 1-méthyl-3-(2-méthylpropyl)cyclohexanol ; de la 7,9-diméthylspiro[5.5]undécan-3-one ; du lavandin abdsdl1111 ; du 2,4-dihydroxy-3,6-diméthylbenzoate de méthyle ; du 3,7-diméthyloctan-1-ol ; du 2-(méthyloxy)-4-propylphénol ; du rosenta ab8428tm ; du 1-{[(1r,2s)-2-(1,1-diméthyléthyl)cyclohexyl]oxy}butan-2-ol ; du headspace freesia ab7254atm ; de la 5-hexyldihydrofuran-2(3h)-one ; du [(2-méthylbutyl)oxy]acétate de prop-2-ényle ; du 1,3-benzodioxole-5-carbaldéhyde ; du [4-(1-méthyléthyl)cyclohexyl]méthanol ; de la 2-hexylcyclopent-2-én-1-one ; du (2e)-3-phénylprop-2-énoate de méthyle ; du 2,6-diméthyloct-7-én-2-ol ; du 2-méthyl-3-[4-(1-méthyléthyl)phényl]propanal ; et le groupe b constitué du 2-phényléthanol ; du 3,7-diméthyloctan-3-ol(tétrahydrolinalol), de l'acétate de 2-(méthyloxy)-4-[(1e)-prop-1-ényl]phényle ; du 4-(méthyloxy)benzaldéhyde ; de la (2e)-1-(2,6,6-triméthylcyclohex-2-én-1-yl)but-2-én-1-one ; de la bergamote ab83921111 ; de la (3e)-3-méthyl-4-(2,6,6-triméthylcyclohex-2-én-1-yl)but-3-én-2-one ; de la cyclopentadécanone ; du cyclohexadécanolide ; du 3-cyclohexylpropanoate de prop-2-ényle ; du 3-[3-(1-méthyléthyl)phényl]butanal ; du carbonate de (3z)-hex-3-ényle et de méthyle ; du (1-méthyl-2-{[(1s,3r,5r)-1,2,2-triméthylbicyclo[3.1.0]hex-3-yl]méthyl}cyclopropyl)méthanol ; du [3,3-bis(méthyloxy)propyl]benzène ; du coumarex i modta ; du propanoate de tricyclo[5.2.1.0{2l6}]déc-4-én-8-yle ; à condition que plus de 5 % mais moins de 15 % de la composition de parfum soit constituée d'ingrédients du groupe a et pour les compositions comprenant moins de 10 % d'ingrédients du groupe a que le pourcentage total des ingrédients du groupe b présents soit supérieur ou égal à la valeur de l'expression 2*(10-a%) où a% est le pourcentage total des ingrédients du groupe a dans la composition

Englisch

perfume compositions comprise between 10% and 30% in total by weight of perfume ingredients selected from two groups, group a, group b, with the provisos that over 5% but less than 15% of the perfume composition must comprise group a ingredients, and for compositions comprising less than 10% of group a ingredients the agregate percentage of group b ingredients present must be at least equal to the expression 2*/10-a%) where a% is the total percentage of group a ingredients in the composition

Letzte Aktualisierung: 2014-12-03
Nutzungshäufigkeit: 1
Qualität:

Französisch

spectrométrie de masse : [m + h] + = 305 exemple 21 : (2s)-1-({[3-(hydroxyméthyt)-9,9-diméthylspiro[5.5]undée-3-y)]-amino}-acétyl)-2-pyrrolidinecarbonitrile : le produit attendu est obtenu selon le procédé de l'exemple 1, en remplaçant, au stade a, le tétrahydro-2h-pyranne-4-carboxaldéhyde par le 4,4-diméthyl-cyclohexane carboxaldéhyde. microanalyse élémentaire : %c %h %n calculé 69,77 9,76 11,62 trouvé 69,54 9,72 11,43 exemple 22 : :(2s)-1-({[2-(1-hydroxy-1-méthyléthyl)-spiro[3.3]hept-2-yl]-amino)-acétyl)2-pyrrolidinecarbonitrile, chlorhydrate : stade a : 2-aminospiro[3.3]heptane-2-carboxylate de méthyle le produit attendu est obtenu selon le procédé décrit au stade e de l'exemple 1, à partir du composé obtenu au stade a de l'exemple 19.

Englisch

mass spectrometry: [m+h]+=305 example 21 (2s)-1-({[3-(hydroxymethyl)-9,9-dimethylspiro[5.5]undec-3-yl]-amino}acetyl)-2-pyrrolidinecarbonitrile the expected product is obtained according to the procedure of example 1, with the replacement of tetrahydro-2h-pyran-4-carboxaldehyde with 4,4-dimethylcyclohexane-carboxaldehyde in step a. elemental microanalysis: % c % h % n calculated 69.77 9.76 11.62 found 69.54 9.72 11.43 example 22 (2s)-1-({[2-(1-hydroxy-1-methylethyl)spiro[3.3]hept-2-yl]amino}-acetyl)-2-pyrrolidinecarbonitrile hydrochloride step a: methyl 2-aminospiro[3.3]heptane-2-carboxylate the expected product is obtained according to the procedure described in step e of example 1, starting from the compound obtained in step a of example 19.

Letzte Aktualisierung: 2014-12-03
Nutzungshäufigkeit: 1
Qualität:

Französisch

rendement : 57% point de fusion : 192-193°c. analyse élémentaire pour c 28 h 24 n 2 o % c % h % n calculé 83,14 5,99 6,92 trouvé 83,58 5,72 7,08 les spectres infrarouge et rmn 1 h sont conformes à ceux du produit attendu. exemple 5 synthèses du composé 1-[(3,4)-dichlorobenzyle]-3,3-diméthylspiro-[indoline-2,3-[3h]-napht-[2,1-b]-[1,4]-oxazine], de structure : synthèse a le produit est obtenu selon la méthode a décrite dans l'exemple 1.

Englisch

example 5 syntheses of the compound 1- (3,4)-dichlorobenzyl!-3,3-dimethylspiro indoline-2,3 3h!naphth- 2,1-b!1,4!oxazine, of structure ##str17## synthesis a the product is obtained according to method a described in example 1.

Letzte Aktualisierung: 2014-12-03
Nutzungshäufigkeit: 1
Qualität:

Französisch

selon l'invention, l'ajout à une composition parfumée d'un ou de plusieurs des produits suivants, de préférence au moins dans les doses minimales en masse suivantes: 1) au moins 0,25 % de 5-méthyl-2-(2-méthylpropyl-1,3-dioxane (camonal); 2) au moins 0,5 % de méthyl 1,4-diméthylcyclohexylcarboxylate (cyprisate); 3) au moins 15 % de 3-(((1-éthyloxy)éthyl)oxy)-3,7-diméthyl-1,6-octadiène (elintaal); et 4) au moins 2,5 % de 7,9-diméthylspiro(5,5)undecan-3-one (dispirone); améliore les propriétés désodorisantes de la composition de manière inattendue.

Englisch

by including in a fragrance composition one or more of the following materials, preferably at least at the following minimum amounts by weight: 1) 5-methyl-2-(2-methylpropyl-1,3-dioxane (camonal) in an amount of at least 0.25 %; 2) methyl 1,4-dimethylcyclohexylcarboxylate (cyprisate) in an amount of at least 0.5 %; 3) 3-(((1-ethyloxy)ethyl)oxy)-3,7-dimethyl-1,6-octadiene (elintaal) in an amount of at least 15 %; and 4) 7,9-dimethylspiro(5,5)undecan-3-one (dispirone) in an amount of at least 2.5 %, the properties of the composition in reducing (counteracting) malodour are enhanced to an unexpected extent.

Letzte Aktualisierung: 2014-12-03
Nutzungshäufigkeit: 1
Qualität:

Französisch

exemple 2 synthèses du composé 1-propyle-3,3-diméthylspiro[indoline-2,3'-[3h]-napht-[2,1-b]-[1,4]-oxazine], de structure : synthèse a le produit est obtenu selon la méthode a décrite dans l'exemple 1. rendement : 62% point de fusion : 123°c. analyse élémentaire pour c 24 h 24 n 2 o % c % h % n calculé 80,87 6,79 7,85 trouvé 81,00 6,92 7,94 les spectres infrarouge et rmn 1 h sont conformes à ceux du produit attendu.

Englisch

example 2 syntheses of the compound 1-propyl-3,3-dimethylspiro indoline-2,3' 3h!naphth- 2,1-b! 1,4!oxazine!, of structure ##str14## synthesis a the product is obtained according to method a described in example 1.

Letzte Aktualisierung: 2014-12-03
Nutzungshäufigkeit: 1
Qualität:

Französisch

3′,6′-bis(éthylamino)-2′,7′-diméthylspiro[isobenzofuranne-1(3h),9′-[9h]-xanthène]-3-one, (cas rn 41382-37-0)

Englisch

3′,6′-bis(ethylamino)-2′,7′-dimethylspiro[isobenzofuran-1(3h),9′-[9h]-xanthen]-3-one, (cas rn 41382-37-0)

Letzte Aktualisierung: 2014-11-21
Nutzungshäufigkeit: 2
Qualität:

Französisch

5,7-diméthoxy-1'-n-butyl-3',3'-diméthylspiro [2 h -1,4-benzoxazine-2,2'-indoline].

Englisch

5,7-dimethoxy-1'-n-butyl-3',3'-dimethylspiro[2 h -1,4-benzoxazine-2,2'-indoline].

Letzte Aktualisierung: 2014-12-04
Nutzungshäufigkeit: 2
Qualität:

Französisch

composition suivant la revendication 1, caractérisée en ce que ladite composition comprend, comme ingrédient parfumant, le 2,2,11-triméthylspiro[5.5]undécan-1-ol, la 2,2-diméthylspiro[5.5]undéc-8-én-1-one, le (1rs,6sr,11sr)-2,2,9,11-tétraméthylspiro[s.5]undéc-8-én-1-ylacétate, le (1rs,6rs,11rs)-2,2,11-triméthylspiro [5.5]undéc-8-én-1-ol, le (1rs,6rs,11rs)-2,2,9,11-tétraméthylspiro[5.5]undéc-8-én-1-ylacétate, le 2,6,8-triméthylspiro[4.5]déc-7-én-1-ol ou le 7-éthyl-11-méthylspiro[5.5]undécan-1-ol ou un mélange de 2,2,10-triméthylspiro[5.5]undéc-8-én-1-one et de 2,2,7-triméthylspiro[5.5]undéc-8-én-l-one ou un mélange de 6,8-diméthylspiro[4.5]déc-7-én-1-ylacétate et de 7,9-diméthylspiro[4.5]déc-7-én-1-ylacétate.

Englisch

a composition according to claim 1, characterized in that said composition comprises, as perfuming ingredient, 2,2,11-dimethylspiro[5.5]undecan-1-ol, 2,2 dimethylspiro[5.5]undec-8-en-1-one, (1rs,6sr,11sr)-2,2,9,11-tetramethyl-spiro[5.5] undec-8-en-1-yl acetate, (1rs,6rs,11rs)-2,2,11-trimethylspiro[5.5]undec-8-en-1-ol, (1rs,6rs,11rs)-2,2,9,11-tetramethylspiro[5.5]undec-8-en-1-yl acetate, 2,6,8-trimethylspiro[4.5]dec-7-en-1-ol or 7-ethyl-11-methylspiro[5.5]undecan-1-ol or a mixture of 2,2,10-trimethylspiro[5.5]undec-8-en-1-one and 2,2,7-trimethylspiro[5.5]undec-8-en-1-one or a mixture of 6,8-dimethyl-spiro[4.5]dec-7-en-1-yl acetate and 7,9-dimethyl-spiro[4.5]dec-7-en-1-yl acetate.

Letzte Aktualisierung: 2014-12-04
Nutzungshäufigkeit: 2
Qualität:

Französisch

composé de la formule (i), comme il est défini dans la revendication 1, à condition que la 2,8-diméthylspiro[5.5]undéc-8-én-1-one, la 2,9-diméthylspiro[5.5]undéc-8-én-1-one, le 1,9-diméthylspiro[5.5]undéc-8-én-1-ol, le 1,8-diméthylspiro[5.5]undéc-8-én-1-ol, le 1,7-diméthylspiro[4.5]déc-7-én-1-ol, le 1,8-diméthylspiro[4.5]déc-7-én-1-ol, la 8,9-diméthylspiro[5.5]undéc-8-én-1-one et la 7,8-diméthylspiro[4.5]déc-7-én-1-one soient exclus.

Englisch

a compound of formula (i), as defined in claim 1, provided that 2,8 dimethyl spiro[5,5]undec-8-en-1-one, 2,9-dimethyl spiro[5,5]undec-8-en-1-one, 1,9 dimethyl spiro[5,5]undec-8-en-1-ol, 1,8-dimethyl spiro[5,5]undec-8-en-1-ol, 1,7-dimethyl spiro[4,5]dec-7-en-1-ol, 1,8-dimethyl spiro[4,5]dec-7-en-1-ol, 8,9-dimethyl spiro[5,5]undec-8-en-1-one and 7,8-dimethyl spiro[4,5]dec-7-en-1-one are excluded.

Letzte Aktualisierung: 2014-12-04
Nutzungshäufigkeit: 2
Qualität:

Französisch

comme composé suivant la revendication 14, le 2,2,9,11-tétraméthylspiro[5.5]undéc-8-én-1-ylacétate, le 2,2,11-triméthylspiro[5.5]undéc-8-én-1-ol, le 2,2,11-triméthylspiro[5.5]undécan-1-ol, la 2,2-diméthylspiro[5.5]undéc-8-én-1-one, (1rs,6sr,11sr)-2,2,9,11-tétraméthylspiro[5.5]undéc-8-én-1-ylacétate, le (1rs,6rs,11rs)-2,2,11-triméthylspiro[5.5]undéc-8-én-1-ol, le 2,6,8-triméthylspiro[4.5]déc-7-én-1-ol, le 7-éthyl-11-méthylspiro[5.5]undécan-1-ol ou le (1rs,6rs,11rs)-2,2,9,11-tétraméthylspiro[5.5]undéc-8-én-1-ylacétate.

Englisch

as compound according to claim 14, 2,2,9,11-tetramethylspiro[5.5]undec-8-en-1-yl acetate, 2,2,1-trimethylspiro[5.5]undec-8-en-1-ol, 2,2,11-trimethylspiro [5.5]undecan-1-ol, 2,2-dimethylspiro[5.5]undec-8-en-1-one, (1rs,6sr,11sr)-2,2,9,11-tetramethylspiro[5.5]undec-8-en-1-yl acetate, (1rs,6rs,11rs)-2,2,11-trimethylspiro [5.5]undec-8-en-1-ol, 2,6,8-trimethylspiro[4.5]dec-7-en-1-ol, 7-ethyl-11-methylspiro[5.5] undecan-1-ol or (1rs,6rs,11rs)-2,2,9,11-tetramethylspiro[5.5]undec-8-en-1-yl acetate.

Letzte Aktualisierung: 2014-12-04
Nutzungshäufigkeit: 2
Qualität:

Französisch

composition constituée d'au moins deux composés de la formule (i), comme il est défini dans la revendication 1, à condition que les compositions constituées de 2,8-diméthylspiro[5.5]undéc-8-én-1-one et de 2,9-diméthylspiro[5.5]undéc-8-én-1-one ou de 1,9-diméthylspiro[5.5]undéc-8-én-1-ol et de 1,8-diméthylspiro[5.5]undéc-8-én-1-ol ou de 1,7-diméthylspiro[4.5]déc-7-én-1-ol et de 1,8-diméthylspiro[4.5]déc-7-én-1-ol soient exclues.

Englisch

a composition consisting of at least two compounds of formula (i), as defined in claim 1, provided that the compositions consisting of 2,8-dimethyl spiro[5,5]undec-8-en-1-one and 2,9-dimethyl spiro[5,5]undec-8-en-1-one, or 1,9-dimethyl spiro[5,5]undec-8-en-1-ol and 1,8-dimethyl spiro[5,5]undec-8-en-1-ol, or 1,7-dimethyl spiro[4,5]dec-7-en-1-ol and 1,8-dimethyl spiro[4,5]dec-7-en-1-ol are excluded.

Letzte Aktualisierung: 2014-12-04
Nutzungshäufigkeit: 2
Qualität:

Französisch

composition contenant essentiellement la 2,2,7,9-tétraméthylspiro[5.5]undéc-8-én-1-one et la 2,2,8,10-tétraméthylspiro[5.5]undéc-8-én-1-one ou composition contenant essentiellement la 2,2,10-triméthylspiro[5.5]undéc-8-én-1-one et la 2,2,7-triméthylspiro[5.5]undéc-8-én-1-one ou composition contenant essentiellement le 6,8-diméthylspiro[4.5]déc-7-én-1-ylacétate et le 7,9-diméthylspiro[4.5]déc-7-én-1-ylacétate

Englisch

a composition containing essentially 2,2,7,9-tetramethylspiro[5.5]undec-8-en-1-one and 2,2,8,10-tetramethylspiro [5.5]undec-8-en-1-one, or a composition containing essentially 2,2,10-trimethylspiro [5.5]undec-8-en-1-one and 2,2,7-trimethylspiro[5.5]undec-8-en-1-one or a composition containing essentially 6,8-dimethyl-spiro[4.5]dec-7-en-1-yl acetate and 7,9-dimethyl-spiro[4.5]dec-7-en-1-yl acetate

Letzte Aktualisierung: 2014-12-04
Nutzungshäufigkeit: 2
Qualität:

Französisch

composé selon la revendication 1 qui est la : cis-5,6a,7,8,9,9a-hexahydro-5-méthyl-3-(phénylméthyl)-cyclopenta[4,5]imidazo[2,1]purin-4-one; 7,8-dihydro-5-méthyl-3-(phénylméthyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; cis-6a,7,8,9,10,10a-hexahydro-5-méthyl-3 h -(phénylméthyl)-3h-benzimidazo[2,1-b]purin-4(5 h )-one; 5,7,8,9-tétrahydro-5-méthyl-3-(phénylméthyl)pyrimido [2,1-b] purin-4(3 h )-one; 7,8-dihydro-8-phényl-5-méthyl-3-(phénylméthyl)-3 h -imidazo [2,1-b]purin-4(5 h )-one; 5',7'-dihydro-5'-méthyl-3'-(phénylméthyl)spiro[cyclohexane-1,8'-(8 h )-imidazo[2,1-b]purin]-4'(3' h )-one; cis-5,6a, 11, 11a-tétrahydro-5-méthyl-3-(phénylméthyl)indéno [1',2':4,5]imidazo[2,1-b]purin-4(3 h )-one; 5',7'-dihydro-2',5' diméthyl-3'-(phénylméthyl)spiro {cyclohexane-1,7'(8' h )-imidazo[2,1-b]purin}-4'(3' h )-one; 7,8-dihydro-2,5,7,7,8(r,s)-pentaméthyl-3 h -imidazo[2,1-b]purin-4(5 h )-one; cis-5,6a,7,11b-tétrahydro-5-méthyl-3-(phénylméthyl)indéno [2',1',:4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-2,5-diméthyl-3-(phénylméthyl)-cyclopent[4,5]imidazo[2,1-b]purin-4-(3 h )-one; 5'-méthyl-3'-(phénylméthyl)-spiro[cyclopentane-1,7'(8' h )-(3' h )-imidazo[2,1-b]purin]-4'(5' h )-one; 7,8-dihydro-2,5,7,7-tétraméthyl-3-(phénylméthyl)-3 h -imidazo [2,1-b]purin-4(5'h)-one; 7,8-dihydro-7(r)-phényl-2,5-diméthyl-3-(phénylméthyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; (±)-7,8-dihydro-2,5-diméthyl-7-éthyl-3-(phénylméthyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 6a(s)-7,8,9,10,10a(r)-hexhydro-2,5-diméthyl-3-(phénylméthyl)-3 h -benzimidazo[2,1-b]purin-4(5 h )-one; 6a(r)-7,8,9,10,10a(s)-hexahydro-2,5-diméthyl-3-(phénylméthyl)-3 h -benzimidazo[2,1-b]purin-4(5 h )-one; 7,8-dihydro-2,5-diméthyl-7(r)-isopropyl-3-(phénylméthyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 7,8-dihydro-2,5,7(r)-triméthyl-3-(phénylméthyl)-3 h -imidazo [2,1-b]purin-4(5 h )-one; cis-7,7a,8,9,10,10a-hexahydro-2,5-diméthyl-3-(phénylméthyl)-3 h -cyclopenta[5,6]pyrimido[2,1-b]purin-4(5h)-one; 7,8-dihydro-2,5-diméthyl-7(s)-(1-méthylpropyl)-3-(phénylméthyl)-3 h -imidazo[2,1-b]purin-4(5h)-one; 7,8-dihydro-2,5-diméthyl-7(r)-(2-méthylpropyl)-3-(phénylméthyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 7,8-dihydro-2,5-diméthyl-7(r,s)-(1-propyl)-3-(phénylméthyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 7,8-dihydro-2,5-diméthyl-7(s)-(1-méthyléthyl)-3-(phénylméthyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 7,8-dihydro-2,5,7,7,8(r,s)-pentaméthyl-3 h -imidazo[2,1-b]purin-4(5 h )-one; 5,7,8,9-tétrahydro-2,5,7,9(r,s)-pentaméthyl-3-(phénylméthyl)-pyrimido[2,1-b]purin-4(3 h )-one; 5,6a(r),7,8,9,9a(s)-hexahydro-2,5-diméthyl-3-(phénylméthyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; 5,6a( s ),7,8,9,9a( r )-hexahydro-2,5-diméthyl-3-(phénylméthyl) cyclopent[4,5]imidazo[2,1-b]purin-4-(3 h )-one; cis-6a,7,8,9,10,10a-hexahydro-2,5-diméthyl-3-(phénylméthyl)-3 h -benzimidazo[2,1-b]purin-4(5 h )-one; 5',7'-dihydro-2',5'-diméthyl-3'-(phénylméthyl)spiro [cyclohexane-1,8'-(8 h )-imidazo[2,1-b]purin]-4'(3' h )-one; cis-5,6a,7,8,9,9a-hexahydro-2,5-diméthyl-3-(phénylméthyl)-cyclohept[6,7]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-méthyl-2-éthyl-3-(phénylméthyl) -cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-6a,7,8,9,10,10a-hexahydro-5-méthyl-2-éthyl-3-(phényméthyl)-3 h -benzimidazo[2,1-b]purin-4-(5 h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-méthyl-2-éthyl-3-(phénylméthyl) -cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-méthyl-2-phényl-3-(phénylméthyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-6a,7,8,9,10,10a-hexahydro-5-méthyl-2-phényl-3-(phénylméthyl)-3 h -benzimidazo[2,1-b]purin-4(5 h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-méthylcyclopenta[4,5]imidazo [2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-2,5-diméthylcyclopenta[4,5]imidazo [2,1-b]purin-4(3 h )-one; cis-5,6a(r),7,8,9,9a(s)-hexahydro-2,5-di-méthyl-cyclopent[4,5] imidazo[2,1-b]purin-4(3 h )-one; 2'-méthyl-3'-spiro{cyclopentane-1,7'(8' h )-(3' h )-imidazo[2,1-b] purin}-4'(5'h)-one; 6a(r),7,8,9,10,10a(s)-hexahydro-2,5-diméthyl-3 h -benzimidazo [2,1-b]purin-4(5 h )-one; 5,7'-dihydro-2',5'-diméthylspiro{cyclohexane-1,7'(8' h )-imidazo[2,1-b]purin}-4'(3' h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-méthyl-3-(phénylméthyl)-cyclopenta[4,5]imidazo[2,1-b]purin-4(3 h )-thione; 5,6a( r ),7,8,9,9a( s )-hexahydro-2,5-diméthyl-3-(phénylméthyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-thione; cis-5,6a,7,8,9,9a-hexahydro-5-méthyl-3-(4-chlorophénylméthyl)cyclopenta[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-méthyl-3-(2-naphthyméthyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; bromophénylméthyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; 5,6a(r)-7,8,9,9a(s)-hexahydro-2,5-diméthyl-3-(4-méthoxyphénylméthyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-2,3,5-triméthylcyclopent[4,5] imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-2-(hydroxyméthyl)-5-méthyl-3-(phénylméthyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3h)one; cis-5,6a,7,8,9,9a-hexahydro-2-méthylthio-5-méthyl-3-(phénylméthyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; l'acide cis-3,4,5,6a,7,8,9,9a-octahydro-5-méthyl-4-oxo-3-(phénylméthyl)-cyclopent[4,5]imidazo[2,1-b]purin-2-carboxylique; le cis-3,4,5,6a,7,8,9,9a-octahydro-5-méthyl-4-oxo-3-(phénylméthyl)-cyclopent[4,5]imidazo[2,1-b]purin-2-carboxylique, méthyl ester; la cis-5,6a,7,8,9,9a-hexahydro-2-bromo-5-méthyl-3-(phénylméthyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3h)one; cis-5,6a,7,8,9,9a-hexahydro-2-(méthylaminosulfonyl)-5-méthyl-3-(phénylméthyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; cis-1-cyclopentyl-5,6a,7,8,9,9a-hexahydro-5-méthylcyclopent[4,5]imidazo[2,1-b]purin-4-(1 h )one; cis-5,6a,7,8,9,9a-hexahydro-3,5-bis-(phénylméthyl)-cyclopent(4,5)imidazo(2,1-b)purin-4(3 h )one; cis-6a,7,8,9,10,10a-hexahydro-3,5-bis-(phénylméthyl)-3 h -benzimidazo[2,1-b]purin-4(5 h )one; cis-3-cyclopentyl-5,6a,7,8,9,9a-hexahydro-5-méthylcyclopent[4,5]imidazo(2,1-b)purin-4(3 h )one; 5'-méthyl-3'-(phénylméthyl)spiro[cyclopentane-1,7'(8' h )-(3'h)-imidazo[2,1-b]purin]-4'(5' h )one; 2',5'-diméthyl-3'-(phénylméthyl)-spiro[cyclopentane-1,7'(8' h )-(3' h )-imidazo[2,1-b]purin]-4'(5' h )one; cis-5,6a,(r)7,8,9,9a(s)-hexahydro-5-méthyl-3-(phénylméthyl)cyclopent[4,5]imidazo(2,1-b)purin-4(3 h )one; cis-3-cyclopentyl-5,6a,7,8,9,9a-hexahydro-2,5-diméthylcyclopent [4,5]imidazo[2,1-b]purin-4(3 h )one;36 5'-méthyl-2'-trifluorométhyl-3'-(phénylméthyl)spiro{cyclopentane-1,7'(8' h )-(3' h )imidazo[2,1-b]purin}-4'(5' h )-one; 7,8-dihydro-5,7,7-triméthyl-2-trifluorométhyl-3-(phénylméthyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; (+/-)-cis-5,6a,7,8,9,9a-hexahydro-5-méthyl-2-trifluorométhyl-3-(phénylméthyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; (+/-)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-diméthyl-3-(phénylméthyl)-3h-pentaleno[6a',1':4,5]imidazo[2,1-b] purin-4(5h)-one; (+)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-diméthyl-3-phénylméthyl-3h-pentaleno[6a',1':4,5]imidazo[2,1-b]purin-4(5h)-one; (-)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-diméthyl-3-phénylméthyl-3h-pentaleno[6a',1':4,5]imidazo[2,1-b]purin-4(5h)-one; (+/-)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-diméthyl-3h-pentaleno[6a',1':4,5]imidazo[2,1-b]purin-4(5h)-one; (+)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-diméthyl-3h-pentaléno [6a',1':4,5]imidazo[2,1-b]purin-4(5h)-one; (-)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-diméthyl-3h-pentaléno [6a',1':4,5]imidazo[2,1-b]purin-4(5h)-one; 6a,7,8,9,10,10a,11,12,13,13a-decahydro-2,5-diméthyl-(3-phénylméthyl)napth[1,8a-d]imidazo[2,1-b]purin-4(5h)one; 7(r)-cyclohexyl-7,8-dihydro-2,5-diméthyl-3-(phénylméthyl)-3h-imidazo[2,1-b]purin-4(3h)-one; 7(r)-cyclohexyl-7,8-dihydro-2,5-diméthyl-3h-imidazo[2,1-b] purin-4(5h)-one; 7(s)-cyclohexyl-7,8-dihydro-2,5-diméthyl-3-(phénylméthyl)-3h-imidazo[2,1-b]purin-4(3h)-one; 7(s)-cyclohexyl-7,8-dihydro-2,5-diméthyl-3h-imidazo[2,1-b] purin-4(5h)-one; 5,6a(r),7,8,9,9a(s)-hexahydro-2,5-diméthyl-3-[(triméthylacétoxy)méthyl]-cyclopent[4,5]imidazo[2,1-b] purin-4(3h)-one; 5,6a(r),7,8,9,9a(s)-hexahydro-2,5-diméthyl-3-(4-pyridylméthyl)-cyclopent[4,5]imidazol[2,1-b]purin-4(3h)-one; 5,6a(r),7,8,9,9a(s)-hexahydro-2,5-diméthyl-3-[2-(1-morpholinyl)éthyl]cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; 5,6a(r),7,8,9,9a(s)-hexahydro-2,5-diméthyl-3-[acétoxyméthyl] cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; 5,6a,7,8,9,9a-hexahydro-2,5,6a-triméthyl-3-(phénylméthyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; 5,6a(r),7(s),8,9,9a-hexahydro-2,5,6a-triméthyl-3-(phénylméthyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; 5,6a(s),7(r),8,9,9a-hexahydro-2,5,6a-triméthyl-3-(phénylméthyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one]; cis-6a,7,8,9,10,10a-hexahydro-2,5,7-triméthyl-3-(phénylméthyl)-3h-benzimidazo[2,1-b]purin-4(5h)-one]; cis-5,6a,7,8,9,9a-hexahydro-2,5,6a-triméthylcyclopent[4,5] imidazo[2,1-b]purin-4(3h)-one; ou la cis-6a,7,8,9,10,10a-hexahydro-2,5,7-triméthyl-3h-benzimidazo [2,1-b]purin-4(5h)-one].

Englisch

a compound according to claim 1 which is: cis-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(phenylmethyl)-cyclopenta[4,5]imidazo[2,1-b]purin-4-one; 7,8-dihydro-5-methyl-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; cis-6a,7,8,9,10,10a-hexahydro-5-methyl-3-(phenylmethyl)-3 h -benzimidazo[2,1-b] purin-4(5 h )-one; 5,7,8,9-tetrahydro-5-methyl-3-(phenylmethyl)pyrimido[2,1-b]purin-4(3 h )-one; 7,8-dihydro-8-phenyl-5-methyl-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 5',7'-dihydro-5'-methyl-3'-(phenylmethyl)spiro[cyclohexane-1,8'-(8 h )-imidazo[2,1-b]purin]-4'(3' h )-one; cis-5,6a,11,11a-tetrahydro-5-methyl-3-(phenylmethyl)indeno[1',2':4,5]imidazo[2,1-b]purin-4(3 h )-one; 5',7'-dihydro-2',5' dimethyl-3'-(phenylmethyl)spiro(cydohexane-1,7'(8' h )-imidazo[2,1-b]purin}-4'(3' h )-one; 7,8-dihydro-2,5,7,7,8(r,s)-pentamethyl-3 h -imidazo[2,1-b]purin-4(5 h )-one; cis-5,6a,7,11b-tetrahydro-5-methyl-3-(phenylmethyl)indeno[2',1',:4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-2,5-dimethyl-3-(phenylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-4-(3 h )-one; 5'-methyl-3'-(phenylmethyl)-spiro[cyclopentane-1,7'(8' h )-(3' h )-imidazo[2,1-b]pulin]-4'(5' h )-one; 7,8-dihydro-2,5,7,7-tetramethyl-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5'h)-one; 7,8-dihydro-7(r)-phenyl-2,5-dimethyl-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; (±)-7,8-dihydro-2,5-dimethyl-7-ethyl-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 6a(s)-7,8,9,10,10a(r)-hexhydro-2,5-dimethyl-3-(phenylmethyl)-3 h -benzimidazo[2,1-b]purin-4(5 h )-one; 6a(r)-7,8,9,10,10a(s)-hexahydro-2,5-dimethyl-3-(phenylmethyl)-3 h -benzimidazo[2,1-b]purin-4(5 h )-one; 7,8-dihydro-2,5-dimethyl-7(r)-isopropyl-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 7,8-dihydro-2,5,7(r)-trimethyl-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; cis-7,7a,8,9,10,10a-hexahydro-2,5-dimethyl-3-(phenylmethyl)-3 h -cyclopenta[5,6]pyrimido[2,1-b]purin-4(5h)-one; 7,8-dihydro-2,5-dimethyl-7(s)-(1-methylpropyl)-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5h)-one; 7,8-dihydro-2,5-dimethyl-7(r)-(2-methylpropyl)-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 7,8-dihydro-2,5-dimethyl-7(r,s)-(1-propyl)-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 7,8-dihydro-2,5-dimethyl-7(s)-(1-methylethyl)-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 7,8-dihydro-2,5,7,7,8(r,s)-pentamethyl-3 h -imidazo[2,1-b]purin-4(5 h )-one; 5,7,8,9-tetrahydro-2,5,7,9(r,s)-pentamethyl-3-(phenylmethyl)-pyrimido[2,1-b]purin-4(3 h )-one; 5,6a( r ),7,8,9,9a( s )-hexahydro-2,5-dimethyl-3-(phenylmethyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; 5,6a( s ),7,8,9,9a( r )-hexahydro-2,5-dimethyl-3-(phenylmethyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-6a,7,8,9,10,10a-hexahydro-2,5-dimethyl-3-(phenylmethyl)-3 h -benzimidazo[2,1-b]purin-4(5 h )-one; 5',7'-dihydro-2',5'-dimethyl-3'-(phenylmethyl)spiro[cyclohexane-1,8'-(8 h )-imidazo[2,1-b]purin]-4'(3' h )-one; cis-5,6a,7,8,9,9a-hexahydro-2,5-dimethyl-3-(phenylmethyl)-cyclohept[6,7]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-methyl-2-ethyl-3-(phenylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-6a,7,8,9,10,10a-hexahydro-5-methyl-2-ethyl-3(phenylmethyl)-3 h -benzimidazo[2,1-b]purin-4-(5 h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-methyl-2-ethyl-3-(phenylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-methyl-2-phenyl-3-(phenylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-6a,7,8,9,10,10a-hexahydro-5-methyl-2-phenyl-3-(phenylmethyl)-3 h -benzimidazo[2,1-b]purin-4(5 h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-methylcyclopenta[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-2,5-dimethylcyclopenta[4,5]imidazo[2,1-b]-purin-4(3 h )-one; cis-5,6a(r),7,8,9,9a(s)-hexahydro-2,5-di-methylcyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; 2'-methyl-3'-spiro{cyclopentane-1,7'(8' h )-(3' h ]-imidazo[2,1-b]purin}-4'(5'h)-one; 6a(r),7,8,9,10,10a(s)-hexahydro-2,5-dimethyl-3 h -benzimidazo[2,1-b]purin-4(5 h )-one; 5',7'-dihydro-2',5'-dimethylspiro{cyclohexane-1,7'(8' h )-imidazo[2,1-b]purin}-4'(3' h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(phenylmethyl)cyclopenta[4,5]imidazo[2,1-b]purin-4(3 h )-thione; 5,6a( r ),7,8,9,9a( s )-hexahydro-2,5-dimethyl-3-(phenylmethyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-thione; cis-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(4-chlorophenylmethyl)cyclopenta[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(2-naphthylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; bromophenylmethyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; 5,6a(r)-7,8,9,9a(s)-hexahydro-2,5-dimethyl-3-(4-methoxyphenylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-2,3,5-trimethylcyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-2-(hydroxymethyl)-5-methyl-3-(phenylmethyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3h)one; cis-5,6a,7,8,9,9a-hexahydro-2-methylthio-5-methyl-3-(phenylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; cis-3,4,5,6a,7,8,9,9a-octahydro-5-methyl-4-oxo-3-(phenylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-2-carboxylic acid; cis-3,4,5,6a,7,8,9,9a-octahydro-5-methyl-4-oxo-3-(phenylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-2-carboxylic acid, methyl ester; cis-5,6a,7,8,9,9a-hexahydro-2-bromo-5-methyl-3-(phenylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3h)one; cis-5,6a,7,8,9,9a-hexahydro-2-(methylaminosulfonyl)-5-methyl-3-(phenylmethyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3h)one; cis-1-cyclopentyl-5,6a,7,8,9,9a-hexahydro-5-methylcyclopent[4,5]imidazo[2,1-b]purin-4-(1 h )one; cis-5,6a,7,8,9,9a-hexahydro-3,5-bis-(phenylmethyl) cyclopent(4,5)imidazo(2,1-b)purin-4(3 h )one; cis-6a,7,8,9,10,10a-hexahydro-3,5-bis-(phenylmethyl)-3 h -benzimidazo[2,1-b]purin-4(5 h )one; cis-3-cyclopentyl-5,6a,7,8,9,9a-hexahydro-5-methylcyclopent[4,5]imidazo(2,1-b)purin-4(3 h )one; 5'-methyl-3'-(phenylmethyl)spiro[cyclopentane-1,7'(8' h )-(3' h )-imidazo[2,1-b]purin]-4'(5' h )one; 2',5'-dimethyl-3'-(phenylmethyl)-spiro[cyclopentane-1,7'(8' h )-(3'h)-imidazo[2,1-b]purin]-4'(5' h )one; cis-5,6a,(r)7,8,9,9a(s)-hexahydro-5-methyl-3-(phenylmethyl)cyclopent[4,5]imidazo(2,1-b)purin-4(3 h )one; cis-3-cyclopentyl-5,6a,7,8,9,9a-hexahydro-2,5-dimethylcyclopent[4,5]imidazo[2,1-b]purin-4(3 h )one ;36 5'-methyl-2'-trifluoromethyl-3'-(phenylmethyl)spiro{cyclo-pentane-1,7'(8'h)-(3' h )imidazo[2,1-b]purin}-4'(5' h )-one; 7,8-dihydro-5,7,7-trimethyl-2-trifluoromethyl-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; (+/-)-cis-5,6a,7,8,9,9a-hexahydro-5-methyl-2-trifluoromethyl-3-(phenylmethyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; (+/-)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-dimethyl-3-(phenylmethyl)-3h-pentaleno[6a',1':4,5] imidazo[2,1-b] purin-4(5h)-one; (+)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-dimethyl-3-phenylmethyl-3h-pentaleno[6a',1':4,5] imidazo[2,1-b] purin-4(5h)-one; (-)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-dimethyl-3-phenylmethyl-3h-pentaleno[6a',1':4,5] imidazo[2,1-b] purin-4(5h)-one; (+/-) 6a,7,8,9,9a,10,11,11a-octahydro-2,5-dimethyl-3h-pentaleno[6a',1':4,5] imidazo[2,1-b] purin-4(5h)-one; (+)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-dimethyl-3h-pentaleno[6a',1':4,5] imidazo[2,1-b] purin-4(5h)-one; (-)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-dimethyl-3h-pentaleno[6a',1':4,5] imidazo[2,1-b] purin-4(5h)-one; 6a,7,8,9,10,10a,11,12,13,13a-decahydro-2,5-dimethyl-(3-phenylmethyl)napth[1,8a-d]imidazo[2,1-b]purin-4(5h)one; 7(r)-cyclohexyl-7,8-dihydro-2,5-dimethyl-3-(phenylmethyl)-3h-imidazo[2,1-b]purin-4(3h)-one; 7(r)-cyclohexyl-7,8-dihydro-2,5-dimethyl-3h-imidazo[2,1-b]purin-4(5h)-one; 7(s)-cyclohexyl-7,8-dihydro-2,5-dimethyl-3-(phenylmethyl)-3h-imidazo[2,1-b]purin-4(3h)-one; 7(s)-cyclohexyl-7,8-dihydro-2,5-dimethyl-3h-imidazo[2,1-b]purin-4(5h)-one; 5,6a(r),7,8,9,9a(s)-hexahydro-2,5-dimethyl-3-[(trimethylacetoxy)methyl]-cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; 5,6a(r),7,8,9,9a(s)-hexahydro-2,5-dimethyl-3-(4-pyridylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; 5,6a(r),7,8,9,9a(s)-hexahydro-2,5-dimethyl-3-[2-(1-morpholinyl)ethyl]cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; 5,6a(r),7,8,9,9a(s)-hexahydro-2,5-dimethyl-3-[acetoxymethyl]cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; 5,6a,7,8,9,9a-hexahydro-2,5,6a-trimethyl-3-(phenylmethyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; 5,6a( r ),7( s ),8,9,9a-hexahydro-2,5,6a-trimethyl-3-(phenylmethyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; 5,6a( s ),7( r ),8,9,9a-hexahydro-2,5,6a-trimethyl-3-(phenylmethyl)cyclopent[4,5jimidazo[2,1-b]purin-4(3h)-one]; cis-6a,7,8,9,10,10a-hexahydro-2,5,7-trimethyl-3-(phenylmethyl)-3h-benzimidazo[2,1-b]purin-4(5h)-one]; cis -5,6a,7,8,9,9a-hexahydro-2,5,6a-trimethylcyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one]; or cis -6a,7,8,9,10,10a-hexahydro-2,5,7-trimethyl-3h-benzimidazo[2,1-b]purin-4(5h)-one].

Letzte Aktualisierung: 2014-12-04
Nutzungshäufigkeit: 2
Qualität:

Französisch

procédé selon la revendication 1 où le composé produit est choisi parmi la : cis-5,6a,7,8,9,9a-hexahydro-5-méthyl-3-(phénylméthyl)-cyclopenta[4,5]imidazo[2,1]purin-4-one; 7,8-dihydro-5-méthyl-3-(phénylméthyl)-3 h -imidazo[2,1-b] purin-4(5 h )-one; cis-6a,7,8,9,10,10a-hexahydro-5-méthyl-3 h -(phénylméthyl)-3h-benzimidazo[2,1-b]purin-4(5 h )-one; 5,7,8,9-tétrahydro-5-méthyl-3-(phénylméthyl)pyrimido [2,1-b]purin-4(3 h )-one; 7,8-dihydro-8-phényl-5-méthyl-3-(phénylméthyl)-3 h -imidazo [2,1-b]purin-4(5 h )-one; 5',7'-dihydro-5'-méthyl-3'-(phénylméthyl)spiro[cyclohexane-1,8'-(8 h )-imidazo[2,1-b]purin]-4'(3' h )-one; cis-5,6a, 11, 11a-tétrahydro-5-méthyl-3-(phénylméthyl)indéno[1',2':4,5]imidazo[2,1-b]purin-4(3 h )-one; 5',7'-dihydro-2',5'diméthyl-3'-(phénylméthyl)spiro {cyclohexane-1,7'(8' h )-imidazo[2,1-b]purin}-4'(3' h )-one; 7,8-dihydro-2,5,7,7,8(r,s)-pentaméthyl-3h-imidazo[2,1-b] purin-4(5 h )-one; cis-5,6a,7,11b-tétrahydro-5-méthyl-3-(phénylméthyl)indéno [2',1',:4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-2,5-diméthyl-3-(phénylméthyl)-cyclopent[4,5]imidazo[2,1-b]purin-4-(3 h )-one; 5'-méthyl-3'-(phénylméthyl)-spiro[cyclopentane-1,7'(8' h )-(3' h )-imidazo[2,1-b]purin]-4'(5' h )-one; 7,8-dihydro-2,5,7,7-tétraméthyl-3-(phénylméthyl)-3 h -imidazo[2,1-b]purin-4(5' h )-one; 7,8-dihydro-7(r)-phényl-2,5-diméthyl-3-(phénylméthyl)-3 h -imidazo[2,1-b]purin-4(5h)-one; (±)-7,8-dihydro-2,5-diméthyl-7-éthyl-3-(phénylméthyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 6a(s)-7,8,9,10,10a(r)-hexhydro-2,5-diméthyl-3-(phénylméthyl)-3 h -benzimidazo[2,1-b]purin-4(5 h )-one; 6a(r)-7,8,9,10,10a(s)-hexahydro-2,5-diméthyl-3-(phénylméthyl)-3 h -benzimidazo[2,1-b]purin-4(5 h )-one; 7,8-dihydro-2,5-diméthyl-7(r)-isopropyl-3-(phénylméthyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 7,8-dihydro-2,5,7(r)-triméthyl-3-(phénylméthyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; cis-7,7a,8,9,10,10a-hexahydro-2,5-diméthyl-3-(phénylméthyl)-3 h -cyclopenta[5,6]pyrimido[2,1-b]purin-4(5h)-one; 7,8-dihydro-2,5-diméthyl-7(s)-(1-méthylpropyl)-3-(phénylméthyl)-3 h -imidazo[2,1-b]purin-4(5h)-one; 7,8-dihydro-2,5-diméthyl-7(r)-(2-méthylpropyl)-3-(phénylméthyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 7,8-dihydro-2,5-diméthyl-7(r,s)-(1-propyl)-3-(phénylméthyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 7,8-dihydro-2,5-diméthyl-7(s)-(1-méthyléthyl)-3-(phénylméthyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 7,8-dihydro-2,5,7,7,8(r,s)-pentaméthyl-3 h -imidazo[2,1-b] purin-4(5 h )-one; 5,7,8,9-tétrahydro-2,5,7,9(r,s)-pentaméthyl-3-(phénylméthyl)-pyrimido[2,1-b]purin-4(3 h )-one; 5,6a( r ),7,8,9,9a( s )-hexahydro-2,5-diméthyl-3-(phénylméthyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; 5,6a( s ),7,8,9,9a( r )-hexahydro-2,5-diméthyl-3-(phénylméthyl)cyclopent[4,5]imidazo[2,1-b]purin-4-(3h)-one; cis-6a,7,8,9,10,10a-hexahydro-2,5-diméthyl-3-(phénylméthyl)-3 h -benzimidazo[2,1-b]purin-4(5 h )-one; 5',7'-dihydro-2',5'-diméthyl-3'-(phénylméthyl)spiro [cyclohexane-1,8'-(8 h )-imidazo[2,1-b]purin]-4'(3' h )-one; cis-5,6a,7,8,9,9a-hexahydro-2,5-diméthyl-3-(phénylméthyl)-cyclohept[6,7]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-méthyl-2-éthyl-3-(phénylméthyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-6a,7,8,9,10,10a-hexahydro-5-méthyl-2-éthyl-3-(phényméthyl)-3 h -benzimidazo[2,1-b]purin-4-(5 h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-méthyl-2-éthyl-3-(phénylméthyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-méthyl-2-phényl-3-(phénylméthyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-6a,7,8,9,10,10a-hexahydro-5-méthyl-2-phényl-3-(phénylméthyl)-3 h -benzimidazo[2,1-b]purin-4(5 h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-méthylcyclopenta[4,5]imidazo [2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-2,5-diméthylcyclopenta[4,5] imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a(r),7,8,9,9a(s)-hexahydro-2,5-di-méthyl-cyclopent [4,5] imidazo[2,1-b]purin-4(3 h )-one; 2'-méthyl-3'-spiro{cyclopentane-1,7'(8' h )-(3' h )-imidazo [2,1-b]purin}-4'(5'h)-one; 6a(r),7,8,9,10,10a(s)-hexahydro-2,5-diméthyl-3 h -benzimidazo[2,1-b]purin-4(5 h )-one; 5,7'-dihydro-2',5'-diméthylspiro{cyclohexane-1,7'(8' h )-imidazo[2,1-b]purin}-4'(3' h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-méthyl-3-(phénylméthyl)-cyclopenta[4,5]imidazo[2,1-b]purin-4(3 h )-thione; 5,6a( r ),7,8,9,9a( s )-hexahydro-2,5-diméthyl-3-(phénylméthyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-thione; cis-5,6a,7,8,9,9a-hexahydro-5-méthyl-3-(4-chlorophénylméthyl)cyclopenta[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-méthyl-3-(2-naphthyméthyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; bromophénylméthyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; 5,6a(r)-7,8,9,9a(s)-hexahydro-2,5-diméthyl-3-(4-méthoxyphénylméthyl)-cyclopent[4,5]imidazo[2,1-b] purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-2,3,5-triméthylcyclopent[4,5] imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-2-(hydroxyméthyl)-5-méthyl-3-(phénylméthyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3h)one; cis-5,6a,7,8,9,9a-hexahydro-2-méthylthio-5-méthyl-3-(phényl-méthyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; l'acide cis-3,4,5,6a,7,8,9,9a-octahydro-5-méthyl-4-oxo-3-(phénylméthyl)-cyclopent[4,5]imidazo[2,1-b]purin-2-carboxylique; le cis-3,4,5,6a,7,8,9,9a-octahydro-5-méthyl-4-oxo-3-(phénylméthyl)-cyclopent[4,5]imidazo[2,1-b]purin-2-carboxylique, méthyl ester; la cis-5,6a,7,8,9,9a-hexahydro-2-bromo-5-méthyl-3-(phénylméthyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3h) one; cis-5,6a,7,8,9,9a-hexahydro-2-(méthylaminosulfonyl)-5-méthyl-3-(phénylméthyl)cyclopent[4,5]imidazo[2,1-b] purin-4(3h)one; cis-1-cyclopentyl-5,6a,7,8,9,9a-hexahydro-5-méthylcyclopent[4,5]imidazo[2,1-b]purin-4 -(1 h )one; cis-5,6a,7,8,9,9a-hexahydro-3,5-bis-(phénylméthyl)-cyclopent(4,5)imidazo(2,1-b)purin-4(3 h )one; cis-6a,7,8,9,10,10a-hexahydro-3,5-bis-(phénylméthyl)-3 h -benzimidazo[2,1-b]purin-4(5 h )one; cis-3-cyclopentyl-5,6a,7,8,9,9a-hexahydro-5-méthylcyclopent[4,5]imidazo(2,1-b)purin-4(3 h )one; 5'-méthyl-3'-(phénylméthyl)spiro[cyclopentane-1,7'(8' h )-(3'h)-imidazo[2,1-b]purin]-4'(5' h )one; 2',5'-diméthyl-3'-(phénylméthyl)-spiro[cyclopentane-1,7'(8' h )-(3' h )-imidazo[2,1-b]purin]-4'(5' h )one; cis-5,6a,(r)7,8,9,9a(s)-hexahydro-5-méthyl-3-(phénylméthyl)cyclopent[4,5]imidazo(2,1-b)purin-4(3 h )one; cis-3-cyclopentyl-5,6a,7,8,9,9a-hexahydro-2,5-diméthylcyclopent [4,5]imidazo[2,1-b]purin-4(3 h )one;36 5'-méthyl-2'-trifluorométhyl-3'-(phénylméthyl)spiro {cyclo-pentane-1,7'(8' h )-(3' h )imidazo[2,1-b]purin}-4'(5' h )-one; 7,8-dihydro-5,7,7-triméthyl-2-trifluorométhyl-3-(phénylméthyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; (+/-)-cis-5,6a,7,8,9,9a-hexahydro-5-méthyl-2-trifluorométhyl-3-(phénylméthyl)cyclopent[4,5]imidazo [2,1-b]purin-4(3h)-one; (+/-)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-diméthyl-3-(phénylméthyl)-3h-pentaleno[6a',1':4,5]imidazo[2,1-b] purin-4(5h)-one; (+)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-diméthyl-3-phénylméthyl-3h-pentaleno[6a',1':4,5]imidazo[2,1-b] purin-4(5h)-one; (-)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-diméthyl-3-phénylméthyl-3h-pentaleno[6a',1':4,5]imidazo[2,1-b] purin-4(5h)-one; (+/-)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-diméthyl-3h-pentaleno[6a',1':4,5]imidazo[2,1-b]purin-4(5h)-one; (+)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-diméthyl-3h-pentaléno[6a',1':4,5]imidazo[2,1-b]purin-4(5h)-one; (-)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-diméthyl-3h-pentaléno[6a',1':4,5]imidazo[2,1-b]purin-4(5h)-one; 6a,7,8,9,10,10a,11,12,13,13a-decahydro-2,5-diméthyl-(3-phénylméthyl)napth[1,8a-d]imidazo[2,1-b]purin-4(5h)one; 7(r)-cyclohexyl-7,8-dihydro-2,5-diméthyl-3-(phénylméthyl)-3h-imidazo[2,1-b]purin-4(3h)-one; 7(r)-cyclohexyl-7,8-dihydro-2,5-diméthyl-3h-imidazo[2,1-b] purin-4(5h)-one; 7(s)-cyclohexyl-7,8-dihydro-2,5-diméthyl-3-(phénylméthyl)-3h-imidazo[2,1-b]purin-4(3h)-one; 7(s)-cyclohexyl-7,8-dihydro-2,5-diméthyl-3h-imidazo[2,1-b] purin-4(5h)-one; 5,6a(r),7,8,9,9a(s)-hexahydro-2,5-diméthyl-3-[(triméthylacétoxy)méthyl]-cyclopent[4,5]imidazo[2,1-b] purin-4(3h)-one; 5,6a(r),7,8,9,9a(s)-hexahydro-2,5-diméthyl-3-(4-pyridylméthyl)-cyclopent[4,5]imidazol[2,1-b]purin-4(3h)-one; 5,6a(r),7,8,9,9a(s)-hexahydro-2,5-diméthyl-3-[2-(1-morpholinyl)éthyl]cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; 5,6a(r),7,8,9,9a(s)-hexahydro-2,5-diméthyl-3-[acétoxyméthyl]cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; 5,6a,7,8,9,9a-hexahydro-2,5,6a-triméthyl-3-(phénylméthyl)cyclopent[4 ,5]imidazo[2,1-b]purin-4(3h)-one; 5,6a(r),7(s),8,9,9a-hexahydro-2,5,6a-triméthyl-3-(phénylméthyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; 5,6a(s),7(r),8,9,9a-hexahydro-2,5,6a-triméthyl-3-(phénylméthyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one]; cis-6a,7,8,9,10,10a-hexahydro-2,5,7-triméthyl-3-(phénylméthyl)-3h-benzimidazo[2,1-b]purin-4(5h)-one]; cis-5,6a,7,8,9,9a-hexahydro-2,5,6a-triméthylcyclopent[4,5] imidazo[2,1-b]purin-4(3h)-one; ou la cis-6a,7,8,9,10,10a-hexahydro-2,5,7-triméthyl-3h-benzimidazo [2,1-b]purin-4(5h)-one].

Englisch

a process according to claim 1 wherein the produced compound is selected from: cis-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(phenylmethyl)-cyclopenta[4,5]imidazo[2,1-b]purin-4-one; 7,8-dihydro-5-methyl-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; cis-6a,7,8,9,10,10a-hexahydro-5-methyl-3-(phenylmethyl)-3 h -benzimidazo[2,1-b] purin-4(5 h )-one; 5,7,8,9-tetrahydro-5-methyl-3-(phenylmethyl)pyrimido[2,1-b]purin-4(3 h )-one; 7,8-dihydro-8-phenyl-5-methyl-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 5',7'-dihydro-5'-methyl-3'-(phenylmethyl)spiro[cyclohexane-1,8'-(8 h )-imidazo[2,1-b]purin]-4'(3' h )-one; cis-5,6a,11,11a-tetrahydro-5-methyl-3-(phenylmethyl)indeno[1',2':4,5]imidazo[2,1-b]purin-4(3 h )-one; 5',7'-dihydro-2',5' dimethyl-3'-(phenylmethyl)spiro{cyclohexane-1,7'(8' h )-imidazo[2,1-b]purin}-4'(3' h )-one; 7,8-dihydro-2,5,7,7,8(r,s)-pentamethyl-3 h -imidazo[2,1-b]purin-4(5 h )-one; cis-5,6a,7,11b-tetrahydro-5-methyl-3-(phenylmethyl)indeno[2',1',:4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-2,5-dimethyl-3-(phenylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-4-(3 h )-one; 5'-methyl-3'-(phenylmethyl)-spiro[cyclopentane-1,7'(8' h )-(3' h )-imidazo[2,1-b]purin]-4'(5' h )-one; 7,8-dihydro-2,5,7,7-tetramethyl-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5'h)-one; 7,8-dihydro-7(r)-phenyl-2,5-dimethyl-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one ; (±)-7,8-dihydro-2,5-dimethyl-7-ethyl-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 6a(s)-7,8,9,10,10a(r)-hexhydro-2,5-dimethyl-3-(phenylmethyl)-3 h -benzimidazo[2,1-b]purin-4(5 h )-one; 6a(r)-7,8,9,10,10a(s)-hexahydro-2,5-dimethyl-3-(phenylmethyl)-3 h -benzimidazo[2,1-b]purin-4(5 h )-one; 7,8-dihydro-2,5-dimethyl-7(r)-isopropyl-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 7,8-dihydro-2,5,7(r)-trimethyl-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; cis-7,7a,8,9,10,10a-hexahydro-2,5-dimethyl-3-(phenylmethyl)-3 h -cyclopenta[5,6]pyrimido[2,1-b]purin-4(5h)-one; 7,8-dihydro-2,5-dimethyl-7(s)-(1-methylpropyl)-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5h)-one; 7,8-dihydro-2,5-dimethyl-7(r)-(2-methylpropyl)-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 7,8-dihydro-2,5-dimethyl-7(r,s)-(1 -propyl)-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 7,8-dihydro-2,5-dimethyl-7(s)-(1-methylethyl)-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; 7,8-dihydro-2,5,7,7,8(r,s)-pentamethyl-3 h -imidazo[2,1-b]purin-4(5 h )-one; 5,7,8,9-tetrahydro-2,5,7,9(r,s)-pentamethyl-3-(phenylmethyl)-pyrimido[2,1-b]purin-4(3 h )-one; 5,6a( r ),7,8,9,9a( s )-hexahydro-2,5-dimethyl-3-(phenylmethyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; 5,6a( s ),7,8,9,9a( r )-hexahydro-2,5-dimethyl-3-(phenylmethyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-6a,7,8,9,10,10a-hexahydro-2,5-dimethyl-3-(phenylmethyl)-3 h -benzimidazo[2,1-b]purin-4(5 h )-one; 5',7'-dihydro-2',5'-dimethyl-3'-(phenylmethyl)spiro[cyclohexane-1,8'-(8 h )-imidazo[2,1-b]purin]-4'(3' h )-one; cis-5,6a,7,8,9,9a-hexahydro-2,5-dimethyl-3-(phenylmethyl)-cyclohept[6,7]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-methyl-2-ethyl-3-(phenylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-6a,7,8,9,10,10a-hexahydro-5-methyl-2-ethyl-3-(phenylmethyl)-3 h -benzimidazo[2,1-b]purin-4-(5 h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-methyl-2-ethyl-3-(phenylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-methyl-2-phenyl-3-(phenylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-6a,7,8,9,10,10a-hexahydro-5-methyl-2-phenyl-3-(phenylmethyl)-3 h -benzimidazo[2,1-b]purin-4(5 h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-methylcyclopenta[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-2,5-dimethylcyclopenta[4,5]imidazo[2,1-b]-purin-4(3 h )-one; cis-5,6a(r),7,8,9,9a(s)-hexahydro-2,5-di-methylcyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; 2'-methyl-3'-spiro{cyclopentane-1,7'(8' h )-(3' h )-imidazo[2,1-b]purin}-4'(5'h)-one; 6a(r),7,8,9,10,10a(s)-hexahydro-2,5-dimethyl-3 h -benzimidazo[2,1-b]purin-4(5 h )-one; 5',7'-dihydro-2',5'-dimethylspiro{cyclohexane-1,7'(8' h )-imidazo[2,1-b]purin}-4'(3' h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(phenylmethyl)cyclopenta[4,5]imidazo[2,1-b]purin-4(3 h )-thione; 5,6a( r ),7,8,9,9a( s )-hexahydro-2,5-dimethyl-3-(phenylmethyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-thione; cis-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(4-chlorophenylmethyl)cyclopenta[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(2-naphthylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; bromophenylmethyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; 5,6a(r)-7,8,9,9a(s)-hexahydro-2,5-dimethyl-3-(4-methoxyphenylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-2,3,5-trimethylcyclopent[4,5]imidazo[2,1-b]purin-4(3 h )-one; cis-5,6a,7,8,9,9a-hexahydro-2-(hydroxymethyl)-5-methyl-3-(phenylmethyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3h)one; cis-5,6a,7,8,9,9a-hexahydro-2-methylthio-5-methyl-3-(phenylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; cis-3,4,5,6a,7,8,9,9a-octahydro-5-methyl-4-oxo-3-(phenylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-2-carboxylic acid; cis-3,4,5,6a,7,8,9,9a-octahydro-5-methyl-4-oxo-3-(phenylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-2-carboxylic acid, methyl ester; cis-5,6a,7,8,9,9a-hexahydro-2-bromo-5-methyl-3-(phenylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3h)one; cis-5,6a,7,8,9,9a-hexahydro-2-(methylaminosulfonyl)-5-methyl-3-(phenylmethyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3h)one; cis-1-cyclopentyl-5,6a,7,8,9,9a-hexahydro-5-methylcyclopent[4,5]imidazo[2,1-b]purin-4-(1 h )one; cis-5,6a,7,8,9,9a-hexahydro-3,5-bis-(phenylmethyl) cyclopent(4,5)imidazo(2,1-b)purin-4(3 h )one; cis-6a,7,8,9,10,10a-hexahydro-3,5-bis-(phenylmethyl)-3 h -benzimidazo[2,1-b]purin-4(5 h )one; cis-3-cyclopentyl-5,6a,7,8,9,9a-hexahydro-5-methylcyclopent[4,5]imidazo(2,1-b)purin-4(3 h )one; 5'-methyl-3'-(phenylmethyl)spiro[cyclopentane-1,7'(8' h )-(3' h )-imidazo[2,1-b]purin]-4'(5' h )one; 2',5'-dimethyl-3'-(phenylmethyl)-spiro[cyclopentane-1,7'(8' h )-(3'h)-imidazo[2,1-b]purin]-4'(5' h )one; cis-5,6a,(r)7,8,9,9a(s)-hexahydro-5-methyl-3-(phenylmethyl)cyclopent[4,5]imidazo(2,1-b)purin-4(3 h )one; cis-3-cyclopentyl-5,6a,7,8,9,9a-hexahydro-2,5-dimethylcyclopent[4,5]imidazo[2,1-b]purin-4(3 h )one;36 5'-methyl-2'-trifluoromethyl-3'-(phenylmethyl)spiro{cyclo-pentane-1,7'(8'h)-(3'h)imidazo[2,1-b]purin}-4'(5' h )-one; 7,8-dihydro-5,7,7-trimethyl-2-trifluoromethyl-3-(phenylmethyl)-3 h -imidazo[2,1-b]purin-4(5 h )-one; (+/-)-cis-5,6a,7,8,9,9a-hexahydro-5-methyl-2-trifluoromethyl-3-(phenylmethyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; (+/-)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-dimethyl-3-(phenylmethyl)-3h-pentaleno[6a',1':4,5] imidazo[2,1-b] purin-4(5h)-one; (+)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-dimethyl-3-phenylmethyl-3h-pentaleno[6a',1':4,5] imidazo[2,1-b] purin-4(5h)-one; (-)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-dimethyl-3-phenylmethyl-3h-pentaleno[6a',1':4,5] imidazo[2,1-b] purin-4(5h)-one; (+/-) 6a,7,8,9,9a,10,11,11a-octahydro-2,5-dimethyl-3h-pentaleno[6a',1':4,5] imidazo[2,1-b] purin-4(5h)-one; (+)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-dimethyl-3h-pentaleno[6a',1':4,5] imidazo[2,1-b] purin-4(5h)-one; (-)-6a,7,8,9,9a,10,11,11a-octahydro-2,5-dimethyl-3h-pentaleno[6a',1':4,5] imidazo[2,1-b] purin-4(5h)-one; 6a,7,8,9,10,10a,11,12,13,13a-decahydro-2,5-dimethyl-(3-phenylmethyl)napth[1,8a-d]imidazo[2,1-b]purin-4(5h)one; 7(r)-cyclohexyl-7,8-dihydro-2,5-dimethyl-3-(phenylmethyl)-3h-imidazo[2,1-b]purin-4(3h)-one; 7(r)-cyclohexyl-7,8-dihydro-2,5-dimethyl-3h-imidazo[2,1-b]purin-4(5h)-one; 7(s)-cyclohexyl-7,8-dihydro-2,5-dimethyl-3-(phenylmethyl)-3h-imidazo[2,1-b]purin-4(3h)-one; 7(s)-cyclohexyl-7,8-dihydro-2,5-dimethyl-3h-imidazo[2,1-b]purin-4(5h)-one; 5,6a(r),7,8,9,9a(s)-hexahydro-2,5-dimethyl-3-[ (trimethylacetoxy)methyl]-cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; 5,6a(r),7,8,9,9a(s)-hexahydro-2,5-dimethyl-3-(4-pyridylmethyl)-cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; 5,6a(r),7,8,9,9a(s)-hexahydro-2,5-dimethyl-3-[2-(1-morpholinyl)ethyl]cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; 5,6a(r),7,8,9,9a(s)-hexahydro-2,5-dimethyl-3-[acetoxymethyl]cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; 5,6a,7,8,9,9a-hexahydro-2,5,6a-trimethyl-3-(phenylmethyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; 5,6a( r ),7( s ),8,9,9a-hexahydro-2,5,6a-trimethyl-3-(phenylmethyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one; 5,6a( s ),7( r ),8,9,9a-hexahydro-2,5,6a-trimethyl-3-(phenylmethyl)cyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one]; cis -6a,7,8,9,10,10a-hexahydro-2,5,7-trimethyl-3-(phenylmethyl)-3h-benzimidazo[2,1-b]purin-4(5h)-one]; cis -5,6a,7,8,9,9a-hexahydro-2,5,6a-trimethylcyclopent[4,5]imidazo[2,1-b]purin-4(3h)-one]; or cis -6a,7,8,9,10,10a-hexahydro-2,5,7-trimethyl-3h-benzimidazo[2,1-b]purin-4(5h)-one].

Letzte Aktualisierung: 2014-12-04
Nutzungshäufigkeit: 2
Qualität:

Französisch

1,2,5,6-tétrahydro-1,1-diméthylspiro[4h-pyrrolo-[3,2,1-ij]quinoléine-2,3'-[3h]-napht[2,1-b][1,4]oxazine].

Englisch

1,2,5,6-tetrahydro-1,1,-dimethylspiro[4h-pyrrolo[3,2,1-ij]quinoline-2,3'-[3h]naphth[2,1-b][1,4]oxazine].

Letzte Aktualisierung: 2014-12-04
Nutzungshäufigkeit: 2
Qualität:

Eine bessere Übersetzung mit
4,401,923,520 menschlichen Beiträgen

Benutzer bitten jetzt um Hilfe:



Wir verwenden Cookies zur Verbesserung Ihrer Erfahrung. Wenn Sie den Besuch dieser Website fortsetzen, erklären Sie sich mit der Verwendung von Cookies einverstanden. Erfahren Sie mehr. OK